The influence of type 2 diabetes mellitus in patients undergoing coronary artery bypass graft surgery - An 8-year prospective cohort study

被引:33
作者
Woods, SE
Smith, JM
Sohail, S
Sarah, A
Engle, A
机构
[1] Bethesda Family Med Residency Program, Cincinnati, OH 45212 USA
[2] Good Samaritan Hosp, Cardiovasc Thorac Surg Grp, Cincinnati, OH USA
[3] Good Samaritan Hosp, E Kenneth Hatton Res Ctr, Cincinnati, OH USA
关键词
cohort study; coronary artery bypass graft; diabetes mellitus;
D O I
10.1378/chest.126.6.1789
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To prospectively assess whether there are any outcome differences between patients with and without type 2 diabetes mellitus undergoing coronary artery by ass graft (CABG) surgery. Study design: This was an 8-year, prospective hospitalization cohort study. Data were collected on 225 variables concurrently, with hospital admission. The main outcome was total operative mortality. In addition, we evaluated 12 morbidity outcomes. To minimize confounding, we controlled for 16 other variables. Results: A total of 6,711 patients were available for our analysis (diabetic patients. 2,178: and nondiabetic patients, 4,533). The diabetic patients were significantly more likely to be women. to have more left ventricular hypertrophy, to have a history of cerebrovascular disease. hypertension, and COPD, to have a greater body surface area, to have higher creatinine levels, to be African-American, to have undergone more elective procedures.. to have a shorter pump time. and to have less of a history, of tobacco use compared to nondiabetic patients (p < 0.05). Multiple regression analysis found no significant difference between the two groups for all 12 morbidity, outcomes of interest. Diabetic patients experienced significantly more mortality than nondiabetic patients (relative risk, 1.67; 95% confidence interval. 1.20 to 2.30; p < 0.004). Conclusion: Patients with type 2 diabetes who are undergoing CABG surgery experience significantly, more total operative mortality, compared to nondiabetic patients, even after controlling for multiple variables. There was no difference between the groups for 12 morbidity outcomes.
引用
收藏
页码:1789 / 1795
页数:7
相关论文
共 19 条
[1]   Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease - The bypass angioplasty revascularization investigation (BARI) [J].
Alderman, E ;
Bourassa, M ;
Brooks, MM ;
Califf, R ;
Chaitman, B ;
Detre, K ;
Faxon, DP ;
Feit, F ;
Frye, RL ;
Hardison, RM ;
Holmes, D ;
Holubkov, R ;
Kouchoukos, N ;
Krone, R ;
Rogers, W ;
Rosen, AD ;
Schaff, H ;
Schwartz, L ;
Siewers, AS ;
Sopko, G ;
SuttonTyrrell, K ;
Whitlow, P .
CIRCULATION, 1997, 96 (06) :1761-1769
[2]   THE PROSPECTIVE CARDIOVASCULAR MUNSTER (PROCAM) STUDY - PREVALENCE OF HYPERLIPIDEMIA IN PERSONS WITH HYPERTENSION AND OR DIABETES-MELLITUS AND THE RELATIONSHIP TO CORONARY HEART-DISEASE [J].
ASSMANN, G ;
SCHULTE, H .
AMERICAN HEART JOURNAL, 1988, 116 (06) :1713-1724
[3]  
BARSNESS G, 1997, CIRCULATION, V96, P633
[4]   Coronary artery bypass performed without the use of cardiopulmonary bypass is associated with reduced cerebral microemboli and improved clinical results [J].
Bowles, BJ ;
Lee, JD ;
Dang, CR ;
Taoka, SN ;
Johnson, EW ;
Lau, EM ;
Nekomoto, K .
CHEST, 2001, 119 (01) :25-30
[5]   Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery [J].
Carson, JL ;
Scholz, PM ;
Chen, AY ;
Peterson, ED ;
Gold, J ;
Schneider, SH .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (03) :418-423
[6]   Glucose-insulin-potassium therapy for treatment of acute myocardial infarction - An overview of randomized placebo-controlled [J].
FathOrdoubadi, F ;
Beatt, KJ .
CIRCULATION, 1997, 96 (04) :1152-1156
[7]  
FERNANDEZ JA, 1991, COMETS POST HALLEY E, V1, P487
[8]   Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction [J].
Haffner, SM ;
Lehto, S ;
Rönnemaa, T ;
Pyörälä, K ;
Laakso, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (04) :229-234
[9]   Mortality, mode of death and risk indicators for death during 5 years after coronary artery bypass grafting among patients with and without a history of diabetes mellitus [J].
Herlitz, J ;
Wognsen, GB ;
Karlson, BW ;
Sjöland, H ;
Karlsson, T ;
Caidahl, K ;
Hartford, M ;
Haglid, M .
CORONARY ARTERY DISEASE, 2000, 11 (04) :339-346
[10]  
Koike Y, 2000, J Cardiol, V35, P9